Indefinite Delivery Contract 36C26122D0063

Award Date 6/10/22
Last Date to Order 9/30/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The U.S. Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the supply of nuclear medicine radiopharmaceuticals. The IDC, with a ceiling value of $1,500,000, has a performance period of April 27, 2023 to April 26, 2028. Under this IDC, the VA has issued several firm-fixed-price delivery orders to Jubilant Radiopharma for the...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Loma Linda Healthcare System to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a small disadvantaged business. The $2,412,781.67 single-award IDC covers the supply of a wide range of radiopharmaceutical products and services, including F-18 FDG, I-123, I-131, Tc-99m, and various other medical isotopes used in diagnostic imaging and cancer treatment procedures....
This Indefinite Delivery Contract (IDC) award to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) was issued by the U.S. Department of Veterans Affairs (VA) for the provision of radiopharmaceuticals. The single-award IDC, valued at a ceiling of $800,000, has an ultimate completion date of June 30, 2030 and was awarded on July 1, 2025. The contract supports the VA's procurement of a range of nuclear medicine products, including Ga-68 Dotatate, iodine I-123,...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a small disadvantaged business. The $576,677.75 single-award IDC, with a performance period through September 2029, will provide the VA with a range of radiopharmaceutical products and services to support nuclear medicine operations at the VA Greater Los Angeles Healthcare...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The contract has a ceiling value of $220,000.00 and a period of performance through March 31, 2030. Under this IDC, Jubilant Radiopharma will provide radiopharmaceuticals and nuclear medicine products to support diagnostic and treatment capabilities for veterans at VA...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The $2.29 million single-award IDC, with a period of performance through January 2030, is for the supply of radiopharmaceuticals, including specialized medical isotopes, diagnostic imaging agents, and therapeutic radioisotopes, to support nuclear medicine procedures, PET scans,...
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the provision of radiopharmaceuticals. The IDC, valued at up to $2.6 million, has an ultimate completion date of March 4, 2029 and is not set-aside. As a subsidiary of Jubilant Life Sciences Limited, Jubilant Radiopharma specializes in manufacturing,...
The federal contract IDV awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, is for the supply of radiopharmaceuticals. The $740,177.94 firm-fixed-price delivery order contract is part of a larger $39.8 million multiple-award Indefinite Delivery Contract (IDC) with the VA's Network Contracting Office 8, as well as additional IDVs with the VA and Defense Health...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit organization, to provide radiopharmaceuticals and related products and services to support diagnostic imaging and treatment procedures at VA medical facilities. The IDC has a potential value of $3,000,000 and runs through September 30, 2028. Jubilant Radiopharma, which is...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, for the procurement of nuclear medicine radiopharmaceuticals. The single-award IDC has a total contract ceiling of $220,000 and a performance period running through March 31, 2030. Jubilant Radiopharma, a for-profit small disadvantaged business, will provide a range of specialized...
  • 36C26122D0063
    Indefinite Delivery Contract
  • 4
    Federal Contract Awards

This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business. The $950,000 single-award IDC covers the provision of nuclear radiopharmaceuticals to support medical operations for the VA's Veterans Integrated Service Network (VISN) 21.

Under this IDC, Jubilant Radiopharma has received multiple firm fixed-price delivery orders to supply critical radiopharmaceutical products such as Gallium 68 Dotatate, iodine I-123, technetium-99m, and other nuclear medicine imaging agents to VA medical facilities and military hospitals across the United States. The delivery orders range from $22,875 to $149,551 and have performance periods of up to one year. No set-aside designations were specified for these orders. This IDC and related task orders enable the VA to efficiently procure radiopharmaceuticals to support diagnostic imaging and treatment procedures for veterans and service members.

Generated 5/20/25, 2:33 PM